'); } -->
Idaho's Division of Medicaid received $114,826 from a settlement reached with Aventis Pharmaceutical, Inc., Attorney General Lawrence Wasden said Thursday.
The settlement resolves allegations that Aventis knowingly misreported the lowest prices for nasal sprays Azmacort, Nasacort and Nasacort AQ.
The agreement was part of a multistate and federal $95.5 million settlement.
Story Comments
We welcome comments but ask that you remain on topic. Some comments may be reprinted elsewhere in the site or in the newspaper. Comments that are profane, personal attacks or otherwise inappropriate or are off topic are subject to removal. Repeat offenders will be blocked. Do not flag comments merely because you disagree with the comment.